Literature DB >> 1709683

Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein.

M Vainzof1, E E Zubrzycka-Gaarn, D Rapaport, M R Passos-Bueno, R C Pavanello, I Pavanello-Filho, M Zatz.   

Abstract

Dystrophin immunohistochemical studies in muscle from Duchenne patients (DMD) have shown a population of fibers with partial labelling. In order to determine whether this is related to a cross reaction or to the presence of dystrophin. 22 DMD patients were studied immunohistochemically, through the concomitant use of antibodies from the N-terminal and the C-terminal regions of the protein. In 2, the reaction was negative while in 2 others 17 and 25% of fibers were positive with both antibodies. In the remainder, a population of partially stained fibers was seen: 11 were positive with both antibodies and in 7 only with the N-terminal one. Apparently, there is no correlation between the proportion of positive fibers and clinical progression, or the presence and pattern of DNA deletions in the central part of the gene. These observations led us to suggest that some truncated protein, intermediate synthesis or degradation products of dystrophin are present in muscle from Duchenne patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709683     DOI: 10.1016/0022-510x(91)90038-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane.

Authors:  T R Helliwell; J M Ellis; R C Mountford; R E Appleton; G E Morris
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

2.  Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation.

Authors:  E M McNally; M R Passos-Bueno; C G Bönnemann; M Vainzof; E de Sá Moreira; H G Lidov; K B Othmane; P H Denton; J M Vance; M Zatz; L M Kunkel
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Immunocytochemical study of dystrophin in cultured mouse muscle cells by the quick-freezing and deep-etching method.

Authors:  Y C Park-Matsumoto; S Ohno; T Baba; T Kobayashi; H Tsukagoshi
Journal:  Histochem J       Date:  1992-06

4.  Deficiency of muscle alpha-actinin-3 is compatible with high muscle performance.

Authors:  Edmar Zanoteli; Renato M Lotuffo; Acary S B Oliveira; Alan H Beggs; Marta Canovas; Mayana Zatz; Mariz Vainzof
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

5.  A new evidence for the maintenance of the sarcoglycan complex in muscle sarcolemma in spite of the primary absence of delta-SG protein.

Authors:  Telma L F Gouveia; Patrícia M Kossugue; Julia F Paim; Mayana Zatz; Louise V B Anderson; Vincenzo Nigro; Mariz Vainzof
Journal:  J Mol Med (Berl)       Date:  2007-01-30       Impact factor: 4.599

6.  Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

7.  Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame.

Authors:  L V Nicholson; K M Bushby; M A Johnson; J T den Dunnen; I B Ginjaar; G J van Ommen
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

8.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

9.  Dysferlin protein analysis in limb-girdle muscular dystrophies.

Authors:  M Vainzof; L V Anderson; E M McNally; D B Davis; G Faulkner; G Valle; E S Moreira; R C Pavanello; M R Passos-Bueno; M Zatz
Journal:  J Mol Neurosci       Date:  2001-08       Impact factor: 2.866

10.  Dmdmdx/Largemyd: a new mouse model of neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies.

Authors:  Poliana C M Martins; Danielle Ayub-Guerrieri; Aurea B Martins-Bach; Paula Onofre-Oliveira; Jackeline M Malheiros; Alberto Tannus; Paulo L de Sousa; Pierre G Carlier; Mariz Vainzof
Journal:  Dis Model Mech       Date:  2013-06-20       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.